• Home
    • HMO/Medical Excess
    • Provider Excess
    • Employer Stop Loss
    • Managed Care Services
    • Capital Management Solutions
    • Letter from the President
    • Underwriting Methodology
    • Core Values
    • Leadership Team
    • Partners and Producers
    • Affiliations
    • Industry News
    • Summit Perspectives
    • Events
  • Contact
    • Forms
    • Articles
    • Brochures
Menu

Summit Re

6920 Pointe Inverness Way, Suite 140
Fort Wayne, IN, 46804
2604073977
 
Extranet - login

Summit Re

  • Home
  • Markets
    • HMO/Medical Excess
    • Provider Excess
    • Employer Stop Loss
    • Managed Care Services
    • Capital Management Solutions
  • Our Company
    • Letter from the President
    • Underwriting Methodology
    • Core Values
    • Leadership Team
    • Partners and Producers
    • Affiliations
  • News
    • Industry News
    • Summit Perspectives
    • Events
  • Contact
  • Library
    • Forms
    • Articles
    • Brochures
blog_banner.jpg

Summit Perspectives

Dystrophic Epidermolysis Bullosa (DEB): What You Need to Know

October 22, 2025 summitre

Dystrophic epidermolysis bullosa (DEB) is a condition caused by mutations in gene COL7A in which skin becomes fragile and prone to blistering. For people with DEB, any injury or friction on the skin can lead to the formation of painful blisters.

Read more
\

Niemann-Pick Disease Type C

September 23, 2025 summitre

Niemann-Pick disease type C (NPC) is a rare progressive genetic disorder characterized by an inability of the body to transport cholesterol and lipids inside of cells. This leads to the abnormal accumulation of these fatty substances within various tissues of the body, including brain tissue.

Read more
\
In Specialty Pharmacy, Summit ReSources, Gene Therapy

As the Cell and Gene Therapy World Turns

September 2, 2025 summitre

August 2025 cell and gene therapy updates

Read more
\

Gene Therapy and Skin Substitute Updates

July 23, 2025 summitre

Read about developments with Elevidys, the Cell and Gene Therapy Access Model, and proposed changes for skin substitutes in 2026.

Read more
\
In Gene Therapy, Cell Therapy, Specialty Pharmacy, Summit ReSources, News

ELEVIDYS on Hold for Non-Ambulatory Patients

June 20, 2025 summitre

Sarepta issued press release on June 15, 2025, titled “Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne.” As it examines the data, the company has initiated several safety initiatives.

Read more
\
In Gene Therapy, Managed care, Specialty Pharmacy

Personalized Gene Therapy

May 23, 2025 summitre

A research team from CHOP and the Perelman School of Medicine at the University of Pennsylvania, supported by the National Institutes of Health, developed a customized gene therapy by utilizing the gene editing platform CRISPR.

Read more
\
In Gene Therapy, Specialty Pharmacy, Summit ReSources

ctDNA testing and treatment of stage 3 colon cancer

April 23, 2025 summitre

Clinical trial for stage 3 colon cancer shows promise.

Read more
\

No Pain, No...Addiction?

March 17, 2025 summitre

On January 30, 2025, the United States FDA approved medication Journavx (suzetrigine), a first-in-class, non-opioid analgesic to treat moderate to severe acute pain in adults.

Read more
\

Gene Therapy Summary 2019-2024 from a Reinsurance/Stop Loss Perspective

February 27, 2025 summitre

Summit Re sees increasing number of gene therapy cases.

Read more
\
In Cell Therapy, Gene Therapy, Specialty Pharmacy, Summit ReSources

Medicare Drug Price Negotiation

January 27, 2025 summitre

CMS initially selected ten drugs covered under Part D for the first cycle of negotiations with drug companies. These drugs include Januvia, NovoLog, Farigia, Enbrel, Jardiance, Stelara, Xarelto, Eilquis, Entresto, and Imbruvica.

Read more
\
Older Posts →
 

Summit Reinsurance Services, Inc. • 6920 Pointe Inverness Way, Suite 140, Fort Wayne, IN 46804 • 260.469.3000

Copyright © 2017-2025 Summit Reinsurance Services, Inc. All rights reserved.


Terms of Use | Website Privacy Policy | HIPAA Privacy Practices | Non-Discrimination Statement and Foreign Language Access

In NY, Summit Re operates under the name Summit Reinsurance Intermediary Brokerage Services.

In CA, Summit Re operates under the name Summit of Indiana Insurance Services.